Literature DB >> 34927218

Three-Dimensional Cell Culture Models of Hepatocellular Carcinoma - a Review.

Irmak Ayvaz1, Dilara Sunay1, Ece Sariyar1, Esra Erdal2,3, Zeynep Firtina Karagonlar4.   

Abstract

INTRODUCTION: Three-dimensional (3D) cell culture studies are becoming extremely common because of their capability to mimic tumor architecture, such as cell-cell and cell-ECM interactions, more efficiently than 2D monolayer systems. These interactions have important roles in defining the tumor cell behaviors, such as proliferation, differentiation, and most importantly, tumor drug response.
OBJECTIVE: This review aims to provide an overview of the methods for 3D tumor spheroid formation to model human tumors, specifically concentrated on studies using hepatocellular carcinoma (HCC) cells.
METHOD: We obtained information from previously published articles. In this review, there is discussion of the scaffold and non-scaffold-based approaches, including hanging drop, bioreactors and 3D bioprinting. RESULTS AND
CONCLUSION: The mimicking of the tumor microenvironment (TME) as tumor spheroids could provide a valuable platform for studying tumor biology. Multicellular tumor spheroids are self-assembled cultures of mixed cells (tumor and stromal cells) organized in a 3D arrangement. These spheroids closely mimic the main features of human solid tumors, such as structural organization, central hypoxia, and overall oxygen and nutrient gradients. Hepatocellular carcinoma (HCC) is the most common liver malignancy, and most difficult to overcome because of its drug resistance and tumor heterogeneity. In order to mimic this highly heterogeneous environment, 3D cell culture systems are needed.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  3D bioprinting; 3D cell culture; Hepatocellular carcinoma (HCC); Tumor microenvironment (TME); Tumor spheroid

Mesh:

Year:  2021        PMID: 34927218     DOI: 10.1007/s12029-021-00772-1

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  68 in total

1.  The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs.

Authors:  Lei Chen; Zhifeng Xiao; Yue Meng; Yannan Zhao; Jin Han; Guannan Su; Bing Chen; Jianwu Dai
Journal:  Biomaterials       Date:  2011-11-10       Impact factor: 12.479

2.  Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells.

Authors:  Zu-Yau Lin; Yen-Hwang Chuang; Wan-Long Chuang
Journal:  Biomed Pharmacother       Date:  2012-03-27       Impact factor: 6.529

3.  Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network.

Authors:  Qi Li; Wei Wang; Tadaaki Yamada; Kunio Matsumoto; Katsuya Sakai; Yoshimi Bando; Hisanori Uehara; Yasuhiko Nishioka; Saburo Sone; Shotaro Iwakiri; Kazumi Itoi; Teruhiro Utsugi; Kazuo Yasumoto; Seiji Yano
Journal:  Am J Pathol       Date:  2011-07-18       Impact factor: 4.307

4.  Morphological studies on a vitamin A-storing cell and its complex with macrophage observed in mouse pancreatic tissues following excess vitamin A administration.

Authors:  N Watari; Y Hotta; Y Mabuchi
Journal:  Okajimas Folia Anat Jpn       Date:  1982-03

5.  Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Authors:  Akira Orimo; Piyush B Gupta; Dennis C Sgroi; Fernando Arenzana-Seisdedos; Thierry Delaunay; Rizwan Naeem; Vincent J Carey; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

Review 6.  Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges.

Authors:  Gan-Lu Deng; Shan Zeng; Hong Shen
Journal:  World J Hepatol       Date:  2015-04-18

7.  Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.

Authors:  Zu-Yau Lin; Wan-Long Chuang
Journal:  Kaohsiung J Med Sci       Date:  2012-10-13       Impact factor: 2.744

8.  Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.

Authors:  Yu Sun; Judith Campisi; Celestia Higano; Tomasz M Beer; Peggy Porter; Ilsa Coleman; Lawrence True; Peter S Nelson
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

9.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

Review 10.  Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma.

Authors:  Cédric Coulouarn; Bruno Clément
Journal:  J Hepatol       Date:  2014-02-12       Impact factor: 25.083

View more
  2 in total

Review 1.  HYDRHA: Hydrogels of hyaluronic acid. New biomedical approaches in cancer, neurodegenerative diseases, and tissue engineering.

Authors:  Maddalena Grieco; Ornella Ursini; Ilaria Elena Palamà; Giuseppe Gigli; Lorenzo Moroni; Barbara Cortese
Journal:  Mater Today Bio       Date:  2022-10-08

2.  Inhibition of eIF6 Activity Reduces Hepatocellular Carcinoma Growth: An In Vivo and In Vitro Study.

Authors:  Alessandra Scagliola; Annarita Miluzio; Giada Mori; Sara Ricciardi; Stefania Oliveto; Nicola Manfrini; Stefano Biffo
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.